Lucemyra
Payments companies reported to CMS as associated with Lucemyra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lucemyra, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lucemyra
These are the largest totals companies reported as associated with Lucemyra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Laughon | Chapel Hill, NC | Pediatrics | $3,300.00 |
| Christoph Hornik | Durham, NC | Pediatric Critical Care Medicine | $3,000.00 |
| Stephen Spielberg | Upper Gwynedd, PA | Pediatrics | $2,000.00 |
| Bernard Gottschalk | Wilmington, NC | Addiction Medicine (Internal Medicine) | $958.28 |
| Venice Sanchez | Newport Beach, CA | Psychiatry | $659.22 |
| Tracey Moreno-Silva | Lumberton, NC | Primary Care | $657.01 |
| Jin Kim | Rancho Cucamonga, CA | Family Medicine | $502.05 |
| Chad Johnston | Du Quoin, IL | Internal Medicine | $497.39 |
| Mary Margaret Hether | Dunn, NC | Nurse Practitioner | $496.92 |
| David Sheehan | Tampa, FL | Psychiatry | $480.00 |
Prescribed Lucemyra?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.